BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27389567)

  • 1. Pregnancy: part of life in chronic myelogenous leukemia.
    Law AD; Dong Hwan Kim D; Lipton JH
    Leuk Lymphoma; 2017 Feb; 58(2):280-287. PubMed ID: 27389567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of chronic myelogenous leukemia in pregnancy.
    Bhandari A; Rolen K; Shah BK
    Anticancer Res; 2015 Jan; 35(1):1-11. PubMed ID: 25550528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing pregnancy in chronic myeloid leukaemia.
    Palani R; Milojkovic D; Apperley JF
    Ann Hematol; 2015 Apr; 94 Suppl 2():S167-76. PubMed ID: 25814083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib.
    Stella S; Tirró E; Massimino M; Vitale SR; Russo S; Pennisi MS; Puma A; Romano C; DI Gregorio S; Innao V; Stagno F; DI Raimondo F; Musolino C; Manzella L
    In Vivo; 2019; 33(5):1593-1598. PubMed ID: 31471409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports.
    Alizadeh H; Jaafar H; Kajtár B
    Ann Saudi Med; 2015; 35(6):468-71. PubMed ID: 26657232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful pregnancies in patients with BCR-ABL-positive leukemias treated with interferon-alpha therapy during the tyrosine kinase inhibitors era.
    Balsat M; Etienne M; Elhamri M; Hayette S; Salles G; Thomas X
    Eur J Haematol; 2018 Dec; 101(6):774-780. PubMed ID: 30179268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal, Fetal, and Neonatal Imatinib Levels With Treatment of Chronic Myeloid Leukemia in Pregnancy.
    Burwick RM; Kuo K; Brewer D; Druker BJ
    Obstet Gynecol; 2017 May; 129(5):831-834. PubMed ID: 28383372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future Directions.
    Bhalla S; Tremblay D; Mascarenhas J
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):488-494. PubMed ID: 27406834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing women of childbearing age with chronic myeloid leukemia: safety and treatment considerations.
    Robertson HF; Buckton MJ; Apperley JF
    Expert Rev Hematol; 2023 May; 16(5):325-332. PubMed ID: 37038615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of pregnant chronic myeloid leukemia patients.
    Abruzzese E; Trawinska MM; de Fabritiis P; Baccarani M
    Expert Rev Hematol; 2016 Aug; 9(8):781-91. PubMed ID: 27352939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breastfeeding in a patient with chronic myeloid leukemia during tyrosine kinase inhibitor therapy.
    Terao R; Nii M; Asai H; Nohara F; Okamoto T; Nagaya K; Azuma H
    J Oncol Pharm Pract; 2021 Apr; 27(3):756-760. PubMed ID: 32787559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery.
    Yadav U; Solanki SL; Yadav R
    J Cancer Res Ther; 2013; 9(3):484-6. PubMed ID: 24125987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report.
    Buyukbayrak EE; Ergen B; Karsidag YK; Kars B; Turan C; Argon D
    Arch Gynecol Obstet; 2008 Aug; 278(2):161-3. PubMed ID: 18193246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring.
    Jabbour E; Kantarjian H
    Am J Hematol; 2016 Feb; 91(2):252-65. PubMed ID: 26799612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When can tyrosine kinase inhibitors be discontinued in patients with chronic myeloid leukemia?
    Mahon FX
    Clin Adv Hematol Oncol; 2019 Feb; 17(2):101-103. PubMed ID: 30845112
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic myeloid leukaemia in pregnancy: call for guidelines.
    P P; Samal R; Ghose S
    J Obstet Gynaecol; 2019 May; 39(4):582-583. PubMed ID: 30744447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Myelogenous Leukemia: Pregnancy in the Era of Stopping Tyrosine Kinase Inhibitor Therapy.
    Berman E; Druker BJ; Burwick R
    J Clin Oncol; 2018 Apr; 36(12):1250-1256. PubMed ID: 29447062
    [No Abstract]   [Full Text] [Related]  

  • 18. Pregnancy in Patients With Chronic Myeloid Leukemia.
    Berman E
    J Natl Compr Canc Netw; 2018 May; 16(5S):660-662. PubMed ID: 29784750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of pregnancy in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors: short report from a single centre.
    Alizadeh H; Jaafar H; Rajnics P; Khan MI; Kajtár B
    Leuk Res; 2015 Jan; 39(1):47-51. PubMed ID: 25455655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis about the management and the perinatal outcomes of pregnancy with chronic myeloid leukemia].
    Wang DP; Liang MY; Zhang XH; Wang SM
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):735-9. PubMed ID: 21176552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.